Loading...

PROPHASE LABS INC Delisting Actions 8-K Filing

PRPH

PROPHASE LABS INC

()

2025 8-K

Strategic Sale Initiated

Investor Webinar

Operational Update

Stock Uplisting Approved

Equity Agreement

Stock Structure Update

Director Resignation

Nasdaq Delisting Notice

Reverse Merger Proposed

Legal Counsel Update

Stock Split Announcement

Stock Split Announcement

Stock Split Action

Stockholder Meeting Results

Legal Unsealing Notice

Financial Results Update

Sales Agreement Signed

Strategic Advisory Agreement

Stockholder Approvals

Agreement Termination

Proxy Statement Update

Financial Results Release

Equity Offerings

Debt-Equity Swaps

Debt-Equity Swaps

Non-Compliance with Listing...

Financial Statements

Earnings Report

Earnings Update

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Update

Earnings Report

Earnings Update

Earnings Report

Earnings Report

Earnings Report

Financial Results

Financial Results for Q3 2021

Quarterly Earnings Reports

Filing with Quantitative Data

Financial Performance

Financial Results

Quantitative Data

Financial Results for Q1 2021

Filing with Quantitative Data

Financial Results

Financial Results

Quarterly Earnings Reports

Quantitative Data

Quarterly Earnings Reports

External Links:

ProPhase Labs, Inc. received a 180-day extension from Nasdaq on June 25, 2025, to regain compliance with its minimum bid price requirement after its stock closed below $1 for 30 consecutive trading days. The new deadline to meet this requirement is December 22, 2025.

AI Assistant

PROPHASE LABS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.